Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

AT&T Stock Is Only for the Iron-Willed Speculator

By Josh Enomoto, InvestorPlace Contributor

Due to its aggressively expansive posture, AT&T stock was very viable in a bull market. But even in this unprecedented black swan event, it does offer some bullish arguments, though at the risk of incredible volatility.

Ignore the Coronavirus Catalyst for ABBV Stock

By Josh Enomoto, InvestorPlace Contributor

Without a coronavirus treatment, the medical community is experimenting with repurposed drugs. In this regard, the present crisis may benefit ABBV stock. Still, AbbVie has other headwinds that investors shouldn’t ignore.

Why You Should Cool Your Contrarian Jets on BAC Stock

By Josh Enomoto, InvestorPlace Contributor

As a contrarian, the steep losses in BAC stock appear like a discounted opportunity. However, as bellwether investments, the big banks plummeting is typically not a great sign.

The Pandemic Makes SQ Stock Even More Relevant

By Josh Enomoto, InvestorPlace Contributor

In this black swan event, almost every investment has struggled, including SQ stock. However, the crisis provides an organic marketing opportunity for Square’s vast payments and business operations services.

This Is No Time to Lose Vigilance on Apple Stock

By Josh Enomoto, InvestorPlace Contributor

Although the appearance of coronavirus case stabilization in New York bolstered both Apple stock and the rest of the markets, that’s not enough of a clear signal to buy with confidence.

Load More